• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

11.69 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tango Therapeutics, Inc. - Common Stock

News headline image
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
November 06, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
November 06, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 07, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics Announces Discontinuation of TNG348 Program
May 23, 2024
From Tango Therapeutics
Via Business Wire
News headline image
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 08, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
March 18, 2024
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics to Participate in Upcoming Investor Conferences
March 06, 2024
From Tango Therapeutics, Inc.
Via Business Wire
Pancreatic Cancer Treatments Poised for Major Advances in 2024
February 07, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Special Purpose Acquisition Companies: The Briscoe Law Firm, PLLC Announce Investigation into the following SPACs
March 08, 2023
From The Briscoe Law Firm, PLLC
Via Business Wire
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Tango Therapeutics, Inc (TNGX) Investigation
February 21, 2023
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
HOOKIPA Pharma Appoints Katia Schlienger, M.D., Ph.D., Chief Medical Officer and Malte Peters, M.D., to Board of Directors
December 15, 2022
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
Tango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021
September 30, 2021
From Tango Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap